Kenneth A. Stauderman
CIK 1969388 · Chief Scientific Officer · last filed 2026-04-07
Kenneth A. Stauderman is a Chief Scientific Officer who has filed 9 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing, for CALC, was dated Apr 7, 2026. Across all open-market trades the lifetime net is +$2.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $11.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.2K
3
9
$2.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Chief Scientific Officer | 12,944 | $0.87 | $11.2K | $2.2K | 7 | 2026-04-07 |
| CalciMedica, Inc. (SCPH) Delisted | Chief Scientific Officer | — | $5.67 | — | $0 | 1 | 2024-08-28 |
| CalciMedica, Inc. (GRAY) Delisted | Chief Scientific Officer | 11,944 | $5.50 | $65.7K | $0 | 1 | 2023-03-22 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-07 | CALC | Grant (A) | — | $0 | EDGAR |
| 2025-07-29 | CALC | Mixed | — | $310 | EDGAR |
| 2025-07-02 | CALC | Buy (P) | +1,000 | $1.9K | EDGAR |
| 2025-06-26 | CALC | Grant (A) | — | $0 | EDGAR |
| 2025-04-25 | CALC | Grant (A) | — | $0 | EDGAR |
| 2024-08-28 | CalciMedica, Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-22 | CALC | Grant (A) | — | $0 | EDGAR |
| 2023-05-10 | CALC | Grant (A) | — | $0 | EDGAR |
| 2023-03-22 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | +11,944 | $0 | EDGAR |